New hope for kids with Tough-to-Treat cancer: drug combo shows promise
NCT ID NCT06341998
Summary
This study tested whether adding the drug sirolimus to a standard chemotherapy combination could help children whose yolk sac tumors have come back or didn't respond to previous treatments. It involved 32 children under 18 who had already tried at least two other platinum-based chemotherapy regimens. The goal was to see if this new combination could better control the disease, potentially leading to a cure or allowing for surgery or radiation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shandong Cancer Hospital and Institute
Jinan, Shandong, 250117, China
Conditions
Explore the condition pages connected to this study.